Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
GenFleet Receives IND Approval from China’s NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, to Initiate Phase I/II Clinical Trials in Patients with Advanced Solid Tumors
Thursday, June 20, 2024GenFleet Therapeutics a biotech company in the clinical stage focusing on advanced therapies for cancer
Golidocitinib Receives Approval in China as the First JAK1-Selective Inhibitor for Treating Relapsed or Refractory Peripheral T-Cell Lymphoma
Thursday, June 20, 2024Dizal a biopharmaceutical company dedicated to developing new treatments for cancer and immunological diseases announced that golidocitinib has received approval from the National Medical Products
Roche Launches New Test for Early Detection of B-cell Lymphoma
Thursday, June 20, 2024Roche has recently launched the VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay the first ISH test approved for clinical use in countries that accept the CE Mark This assay aids pathologists in distinguishing between Bcell malignancies an...
Junshi Biosciences Gains Approval for sNDA of Toripalimab as First-Line Therapy for Small Cell Lung Cancer
Wednesday, June 19, 2024Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company focused on developing innovative therapies announced that the National Medical Products
Ionis and Otsuka Expand Licensing Agreement for Hereditary Angioedema Drug Donidalorsen in Asia Pacific
Wednesday, June 19, 2024Ionis Pharmaceuticals Inc has finalized a licensing agreement with Otsuka Pharmaceutical Co Ltd granting Otsuka exclusive rights to donidalorsen in the AsiaPacific region
Spyre Therapeutics Initiates Phase 1 Study of SPY001, a Novel Antibody Targeting α4β7 for Inflammatory Bowel Disease Therapy
Wednesday, June 19, 2024Spyre Therapeutics Inc a biotechnology firm focused on the development of innovative treatments for Inflammatory Bowel Disease has announced the initiation of its first clinical trial
ReviR Therapeutics and Asieris Pharmaceuticals Reach Milestone in RNA-Targeted Cancer Therapy Development
Tuesday, June 18, 2024ReviR Therapeutics a biotechnology firm focused on creating small molecule RNA splicing modulators for neurogenetic diseases and cancer and Asieris Pharmaceuticals a global leader in developing
FDA Approves Phase II Study of Ruxoprubart for ANCA-Associated Vasculitis
Tuesday, June 18, 2024NovelMed is pleased to announce that Ruxoprubart an experimental drug has received approval from the US Food and Drug Administration FDA to initiate a clinical trial focused on patients with ANCA Associated Vasculitis AAV is a rare autoimmune disorde...
Northwest Biotherapeutics Acquires Exclusive Rights to Dendritic Cell Technology Suite
Tuesday, June 18, 2024Northwest Biotherapeutics a biotechnology company focused on DCVax personalized immune therapies for solid tumor cancers announced on June that it has acquired
Imfinzi, in Combination With Chemotherapy, Has Received Approval in the US for Treating Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficiency
Monday, June 17, 2024AstraZenecas Imfinzi has received FDA approval in the United States for the treatment of adult patients
